The global induced pluripotent stem cell (iPSC) market was valued at USD 2.1 billion in 2023, growing at a CAGR of 9.6% from 2024 to 2033. The market is expected to reach USD 5.2 billion by 2033. Due to the growing need for vaccine production, higher expenditures in the industry, and an expanding application portfolio from ongoing research and development efforts, the iPSC market is expanding quickly.
Nhà Cái Mb88
Mary Paul
Gokul Healthcare
The Vital Media - Advertising Agency In Ahmedabad
Mehta Transportation
Emilie Boland
Db Distro
Atria Web Solutions
89bet
Stone Masonry London